LLY - Eli Lilly extends expiration of tender offer to acquire Point Biopharma
2023-11-08 19:27:26 ET
More on Eli Lilly, Point Biopharma Global
- Eli Lilly and Co (LLY) Q3 2023 Earnings Conference Call Transcript
- Eli Lilly and Company 2023 Q3 - Results - Earnings Call Presentation
- Eli Lilly wins FDA approval for weight loss therapy (update)
- Eli Lilly POINTs Toward Radiopharmaceutical Ambitions
- POINT Biopharma trades through deal price with Eli Lilly
For further details see:
Eli Lilly extends expiration of tender offer to acquire Point Biopharma